25 XP   0   0   10

Genex Pharmaceutical Inc
Buy, Hold or Sell?

Let's analyse Genex Pharmaceutical Inc together

PenkeI guess you are interested in Genex Pharmaceutical Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Genex Pharmaceutical Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Genex Pharmaceutical Inc

I send you an email if I find something interesting about Genex Pharmaceutical Inc.

Quick analysis of Genex Pharmaceutical Inc (30 sec.)










What can you expect buying and holding a share of Genex Pharmaceutical Inc? (30 sec.)

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.00
How sure are you?

+ What do you gain per year?

Total Gains per Share
$0.00
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0001 - $0.0001
How sure are you?
50%

1. Valuation of Genex Pharmaceutical Inc (5 min.)




Live pricePrice per Share (EOD)

$0.00

2. Growth of Genex Pharmaceutical Inc (5 min.)




Is Genex Pharmaceutical Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$4.7m$4m$673k14.2%

How much money is Genex Pharmaceutical Inc making?

Current yearPrevious yearGrowGrow %
Making money$342.5k$618.9k-$276.4k-80.7%
Net Profit Margin10.6%25.4%--

How much money comes from the company's main activities?

3. Financial Health of Genex Pharmaceutical Inc (5 min.)




What can you expect buying and holding a share of Genex Pharmaceutical Inc? (5 min.)

Welcome investor! Genex Pharmaceutical Inc's management wants to use your money to grow the business. In return you get a share of Genex Pharmaceutical Inc.

What can you expect buying and holding a share of Genex Pharmaceutical Inc?

First you should know what it really means to hold a share of Genex Pharmaceutical Inc. And how you can make/lose money.

Speculation

The Price per Share of Genex Pharmaceutical Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genex Pharmaceutical Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genex Pharmaceutical Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash.
Based on historical numbers we can estimate the returns while holding a share of Genex Pharmaceutical Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share
Usd Dividend Per Share
Usd Total Gains Per Share
Usd Price Per Share0.29-0.29-0.13-0.31-0.31-
Price to Earnings Ratio0.00-0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio
Price to Book Ratio0.00-0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share--
Usd Book Value Change Per Share--
Usd Total Gains Per Share--
Gains per Quarter (10000000 shares)--
Gains per Year (10000000 shares)--
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1---10---10
2---10---10
3---10---10
4---10---10
5---10---10
6---10---10
7---10---10
8---10---10
9---10---10
10---10---10

Fundamentals of Genex Pharmaceutical Inc

About Genex Pharmaceutical Inc

Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin City, the People's Republic of China.

Fundamental data was last updated by Penke on 2024-05-01 00:29:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry

1.1. Profitability of Genex Pharmaceutical Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Genex Pharmaceutical Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Genex Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 10.6% means that $0.11 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genex Pharmaceutical Inc:

  • The MRQ is 10.6%. The company is making a huge profit. +2
  • The TTM is 10.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.6%TTM10.6%0.0%
TTM10.6%YOY25.4%-14.8%
TTM10.6%5Y26.0%-15.5%
5Y26.0%10Y26.0%0.0%
1.1.2. Return on Assets

Shows how efficient Genex Pharmaceutical Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genex Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.0% Return on Assets means that Genex Pharmaceutical Inc generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genex Pharmaceutical Inc:

  • The MRQ is 4.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.0%TTM4.0%0.0%
TTM4.0%YOY10.8%-6.8%
TTM4.0%5Y15.8%-11.9%
5Y15.8%10Y15.8%0.0%
1.1.3. Return on Equity

Shows how efficient Genex Pharmaceutical Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genex Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.2% Return on Equity means Genex Pharmaceutical Inc generated $0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genex Pharmaceutical Inc:

  • The MRQ is 7.2%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.2%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.2%TTM7.2%0.0%
TTM7.2%YOY15.2%-8.0%
TTM7.2%5Y20.0%-12.8%
5Y20.0%10Y20.0%0.0%

1.2. Operating Efficiency of Genex Pharmaceutical Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Genex Pharmaceutical Inc is operating .

  • Measures how much profit Genex Pharmaceutical Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genex Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 14.4% means the company generated $0.14  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genex Pharmaceutical Inc:

  • The MRQ is 14.4%. The company is operating less efficient.
  • The TTM is 14.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ14.4%TTM14.4%0.0%
TTM14.4%YOY34.7%-20.3%
TTM14.4%5Y32.1%-17.7%
5Y32.1%10Y32.1%0.0%
1.2.2. Operating Ratio

Measures how efficient Genex Pharmaceutical Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are $0.97 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Genex Pharmaceutical Inc:

  • The MRQ is 0.968. The company is less efficient in keeping operating costs low.
  • The TTM is 0.968. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.968TTM0.9680.000
TTM0.968YOY0.742+0.226
TTM0.9685Y0.790+0.178
5Y0.79010Y0.7900.000

1.3. Liquidity of Genex Pharmaceutical Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Genex Pharmaceutical Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.62 means the company has $0.62 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Genex Pharmaceutical Inc:

  • The MRQ is 0.615. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.615. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.615TTM0.6150.000
TTM0.615YOY0.939-0.324
TTM0.6155Y3.456-2.840
5Y3.45610Y3.4560.000
1.3.2. Quick Ratio

Measures if Genex Pharmaceutical Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genex Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.35 means the company can pay off $0.35 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genex Pharmaceutical Inc:

  • The MRQ is 0.352. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.352. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.352TTM0.3520.000
TTM0.352YOY0.540-0.187
TTM0.3525Y2.368-2.015
5Y2.36810Y2.3680.000

1.4. Solvency of Genex Pharmaceutical Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Genex Pharmaceutical Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genex Pharmaceutical Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.45 means that Genex Pharmaceutical Inc assets are financed with 45.2% credit (debt) and the remaining percentage (100% - 45.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genex Pharmaceutical Inc:

  • The MRQ is 0.452. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.452. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.452TTM0.4520.000
TTM0.452YOY0.292+0.160
TTM0.4525Y0.276+0.176
5Y0.27610Y0.2760.000
1.4.2. Debt to Equity Ratio

Measures if Genex Pharmaceutical Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genex Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 82.5% means that company has $0.82 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genex Pharmaceutical Inc:

  • The MRQ is 0.825. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.825. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.825TTM0.8250.000
TTM0.825YOY0.413+0.412
TTM0.8255Y0.424+0.401
5Y0.42410Y0.4240.000

2. Market Valuation of Genex Pharmaceutical Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Genex Pharmaceutical Inc generates.

  • Above 15 is considered overpriced but always compare Genex Pharmaceutical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 0.00 means the investor is paying $0.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genex Pharmaceutical Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genex Pharmaceutical Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Genex Pharmaceutical Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Genex Pharmaceutical Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Genex Pharmaceutical Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share----0%-0%-0%-0%
Current Ratio--0.6150.6150%0.939-34%3.456-82%3.456-82%
Debt To Asset Ratio--0.4520.4520%0.292+55%0.276+64%0.276+64%
Debt To Equity Ratio--0.8250.8250%0.413+100%0.424+95%0.424+95%
Eps----0%-0%-0%-0%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap----0%-0%-0%-0%
Net Profit Margin--0.1060.1060%0.254-58%0.260-59%0.260-59%
Operating Margin--0.1440.1440%0.347-59%0.321-55%0.321-55%
Operating Ratio--0.9680.9680%0.742+30%0.790+23%0.790+23%
Pb Ratio----0%-0%-0%-0%
Pe Ratio----0%-0%-0%-0%
Price Per Share0.000-289900%0.2900.2900%0.130+123%0.310-6%0.310-6%
Price To Free Cash Flow Ratio----0%-0%-0%-0%
Quick Ratio--0.3520.3520%0.540-35%2.368-85%2.368-85%
Return On Assets--0.0400.0400%0.108-63%0.158-75%0.158-75%
Return On Equity--0.0720.0720%0.152-53%0.200-64%0.200-64%
Usd Book Value--4739562.0004739562.0000%4066536.000+17%3683791.250+29%3683791.250+29%
Usd Book Value Per Share----0%-0%-0%-0%
Usd Eps----0%-0%-0%-0%
Usd Free Cash Flow--528405.000528405.0000%1176697.000-55%791193.250-33%791193.250-33%
Usd Market Cap----0%-0%-0%-0%
Usd Price Per Share0.000-289900%0.2900.2900%0.130+123%0.310-6%0.310-6%
Usd Profit--342549.000342549.0000%618963.000-45%649946.750-47%649946.750-47%
Usd Revenue--3237155.0003237155.0000%2438229.000+33%2629169.000+23%2629169.000+23%
 EOD+1 -1MRQTTM+0 -0YOY+3 -125Y+3 -1210Y+3 -12

3.2. Fundamental Score

Let's check the fundamental score of Genex Pharmaceutical Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Net Profit Margin (MRQ)Greater than00.106
Operating Margin (MRQ)Greater than00.144
Quick Ratio (MRQ)Greater than10.352
Current Ratio (MRQ)Greater than10.615
Debt to Asset Ratio (MRQ)Less than10.452
Debt to Equity Ratio (MRQ)Less than10.825
Return on Equity (MRQ)Greater than0.150.072
Return on Assets (MRQ)Greater than0.050.040
Total4/8 (50.0%)

3.3. Technical Score

Let's check the technical score of Genex Pharmaceutical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2007-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets8,649
Total Liabilities3,909
Total Stockholder Equity4,740
 As reported
Total Liabilities 3,909
Total Stockholder Equity+ 4,740
Total Assets = 8,649

Assets

Total Assets8,649
Total Current Assets2,140
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 430
Net Receivables 1,225
Inventory 485
Total Current Assets  (as reported)2,140
Total Current Assets  (calculated)2,140
+/-0
Long-term Assets
Property Plant Equipment 196
Long Term Investments 12,527
Long-term Assets  (as reported)0
Long-term Assets  (calculated)12,723
+/- 12,723

Liabilities & Shareholders' Equity

Total Current Liabilities3,478
Long-term Liabilities0
Total Stockholder Equity4,740
Total Current Liabilities
Short Long Term Debt 1,141
Accounts payable 14
Other Current Liabilities 1,801
Total Current Liabilities  (as reported)3,478
Total Current Liabilities  (calculated)2,956
+/- 522
Long-term Liabilities
Other Liabilities 431
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)431
+/- 431
Total Stockholder Equity
Common Stock2
Retained Earnings 3,051
Other Stockholders Equity 540
Total Stockholder Equity (as reported)4,740
Total Stockholder Equity (calculated)3,593
+/- 1,147
Other
Net Tangible Assets 4,740
Net Working Capital -1,338



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2007-12-312006-12-312005-12-312004-12-31
> Total Assets 
2,939
4,422
5,745
8,649
8,6495,7454,4222,939
   > Total Current Assets 
2,708
4,245
1,534
2,140
2,1401,5344,2452,708
       Cash And Cash Equivalents 
326
296
192
430
430192296326
       Net Receivables 
1,859
3,079
882
1,225
1,2258823,0791,859
       Inventory 
523
455
460
485
485460455523
   > Long-term Assets 0000
       Property Plant Equipment 
231
177
131
196
196131177231
       Long Term Investments 
0
0
0
12,527
12,527000
       Other Assets 
0
0
4,080
6,312
6,3124,08000
> Total Liabilities 
326
1,105
1,678
3,909
3,9091,6781,105326
   > Total Current Liabilities 
326
1,068
1,634
3,478
3,4781,6341,068326
       Short Long Term Debt 
97
0
0
1,141
1,1410097
       Accounts payable 
200
2
5
14
1452200
       Other Current Liabilities 
76
537
1,046
1,801
1,8011,04653776
   > Long-term Liabilities 0000
       Other Liabilities 
0
37
45
431
43145370
       Deferred Long Term Liability 
0
64
88
856
85688640
> Total Stockholder Equity
2,613
3,316
4,067
4,740
4,7404,0673,3162,613
   Common Stock
2
2
2
2
2222
   Retained Earnings 
1,464
2,089
2,708
3,051
3,0512,7082,0891,464
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 
0
78
210
540
540210780



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2007-12-31)

Gross Profit (+$)
totalRevenue3,237
Cost of Revenue-363
Gross Profit2,8742,874
 
Operating Income (+$)
Gross Profit2,874
Operating Expense-2,771
Operating Income466103
 
Operating Expense (+$)
Research Development196
Selling General Administrative2,212
Selling And Marketing Expenses0
Operating Expense2,7712,408
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income466
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)734199
EBIT - interestExpense = 466
734
343
Interest Expense0
Earnings Before Interest and Taxes (EBIT)466734
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax734
Tax Provision-0
Net Income From Continuing Ops343734
Net Income343
Net Income Applicable To Common Shares343
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net2670
 

Technical Analysis of Genex Pharmaceutical Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genex Pharmaceutical Inc. The general trend of Genex Pharmaceutical Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genex Pharmaceutical Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genex Pharmaceutical Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.0001 > 0.0001 > 0.0001.

Tweet this
Genex Pharmaceutical Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genex Pharmaceutical Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genex Pharmaceutical Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genex Pharmaceutical Inc. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genex Pharmaceutical Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Genex Pharmaceutical Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Genex Pharmaceutical Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Genex Pharmaceutical Inc Daily Moving Average Convergence/Divergence (MACD) ChartGenex Pharmaceutical Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genex Pharmaceutical Inc. The current adx is 0.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is 0/(-7 +7).

  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Genex Pharmaceutical Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genex Pharmaceutical Inc. The current sar is 0.0001.

Genex Pharmaceutical Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genex Pharmaceutical Inc. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Genex Pharmaceutical Inc Daily Relative Strength Index (RSI) ChartGenex Pharmaceutical Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genex Pharmaceutical Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genex Pharmaceutical Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Genex Pharmaceutical Inc Daily Stochastic Oscillator ChartGenex Pharmaceutical Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genex Pharmaceutical Inc. The current cci is -66.66666667.

Genex Pharmaceutical Inc Daily Commodity Channel Index (CCI) ChartGenex Pharmaceutical Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genex Pharmaceutical Inc. The current cmo is 0.

Genex Pharmaceutical Inc Daily Chande Momentum Oscillator (CMO) ChartGenex Pharmaceutical Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genex Pharmaceutical Inc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Genex Pharmaceutical Inc Daily Williams %R ChartGenex Pharmaceutical Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Genex Pharmaceutical Inc.

Genex Pharmaceutical Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genex Pharmaceutical Inc. The current atr is 0.

Genex Pharmaceutical Inc Daily Average True Range (ATR) ChartGenex Pharmaceutical Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genex Pharmaceutical Inc. The current obv is 0.

Genex Pharmaceutical Inc Daily On-Balance Volume (OBV) ChartGenex Pharmaceutical Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genex Pharmaceutical Inc. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Genex Pharmaceutical Inc Daily Money Flow Index (MFI) ChartGenex Pharmaceutical Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genex Pharmaceutical Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

Genex Pharmaceutical Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genex Pharmaceutical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Genex Pharmaceutical Inc with someone you think should read this too:
  • Are you bullish or bearish on Genex Pharmaceutical Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genex Pharmaceutical Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genex Pharmaceutical Inc

I send you an email if I find something interesting about Genex Pharmaceutical Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Genex Pharmaceutical Inc.

Receive notifications about Genex Pharmaceutical Inc in your mailbox!